Anthelmintic drug, levamisole, is being reviewed by the EMA’s safety committee for its links to debilitating brain disease, leukoencephalopathy.
Medscape Medical News
Source link : https://www.medscape.com/viewarticle/ema-deworming-med-under-review-brain-side-effects-2025a1000njh?src=rss
Author :
Publish date : 2025-09-05 14:29:00
Copyright for syndicated content belongs to the linked Source.